Abstract
Purpose
The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety of microwave ablation (MWA) in the treatment of malignant musculoskeletal tumours.
Materials and methods
Sixteen bone and soft-tissue malignant tumours were prospectively included and were treated by CT-guided MWA. The percentage and size of necrosis of the lesions were measured by contrast-enhanced MRI before the procedure and after 1, 3, 6 and 12 months. mRECIST criteria were used to assess tumour response. Procedural success was defined as ≥80 % necrosis. Patient pain (as assessed using a numeric visual scale (NVS)) and side effects were noted.
Results
Six osteolytic metastases, five osteoblastic metastases and five soft tissue sarcomas were treated. At 1 month, 40 % were treated completely, the percentage of necrosis was 85 ± 30.4 %, and the success rate was 80 %. At 3, 6 and 12 months the success rate was 80 %, 76.9 % and 63.6 %, respectively. At 12 months, four lesions (36.3 %) still had no recurrence. Mean NVS during the procedure was 3.5 ± 2.8. One patient had transitory sciatica without neurological deficit that was treated medically.
Conclusion
CT-guided MWA of bone and soft-tissue malignant tumours is efficient, well tolerated and has good short-term anti-cancer effects.
Key Points
• CT-guided MWA is efficient in treating musculoskeletal malignant tumours.
• This prospective pilot study showed MWA induces high percentages of tumour necrosis.
• MWA has good short-term anti-cancer effects.
• MWA has healing potential when lesions can be completely necrosed.
• CT-guided MWA under equimolar mixture of oxygen-nitrous oxide inhalation is well tolerated.
Similar content being viewed by others
References
Nordlinger B, De Sena G, Szawlowski A et al (1983) Surgical resection of hepatic metastases of cancers of the colon and rectum. Gastroentérologie Clinique Et Biologique 7:240–243
Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol Off J Am Soc Clin Oncol 13:8–10
Filippiadis DK, Tutton S, Mazioti A, Kelekis A (2014) Percutaneous image-guided ablation of bone and soft tissue tumours: a review of available techniques and protective measures. Insights Imaging 5:339–346
Moser T, Buy X, Goyault G et al (2008) Image-guided ablation of bone tumors: review of current techniques. J Radiol 89:461–471
Xie C, Jeys L, James SLJ (2015) Radiofrequency ablation of chondroblastoma: long-term clinical and imaging outcomes. Eur Radiol 25:1127–1134
Kastler A, Alnassan H, Pereira PL et al (2013) Analgesic effects of microwave ablation of bone and soft tissue tumors under local anesthesia. Pain Med (Malden, Mass) 14:1873–1881
Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306
Miguel R (2000) Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control 7:149–156
de Baere T (2011) New techniques of tumor ablation (microwaves, electroporation). Journal De Radiologie 92:789–795
Brace CL (2009) Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 38:61–67
Palussière J (2010) L’ablation tumorale percutanée: où en est-on ? Oncologie 12:213–218
Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities--part II. J Vasc Interv Radiol 12:1135–1148
Pusceddu C, Sotgia B, Fele RM, Melis L (2013) Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol 24:229–233
Yang X, Ye X, Zheng A et al (2014) Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol 110:758–763
Fournier L, Ammari S, Thiam R, Cuénod C-A (2014) Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson. Diagn Interv Imaging 95:689–703
Llovet JM, Di Bisceglie AM, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698–711
Gangi A, Tsoumakidou G, Buy X, Quoix E (2010) Quality improvement guidelines for bone tumour management. Cardiovasc Intervent Radiol 33:706–713
Kastler B, Boulahdour H, Barral FG et al (2005) Pain management in bone metastasis of pulmonary origin: new interventional and metabolic techniques. Revue Des Maladies Respiratoires 22:8S94–8S100
Dixmérias F, Palussière J (2011) Management of painful bone metastases. Journal De Radiologie 92:796–800
Yu J, Liang P, Yu X-L et al (2012) US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology 263:900–908
Durick NA, Laeseke PF, Broderick LS et al (2008) Microwave ablation with triaxial antennas tuned for lung: results in an in vivo porcine model. Radiology 247:80–87
Kastler A, Alnassan H, Aubry S, Kastler B (2014) Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol 25:1470–1475
Carrafiello G, Laganà D, Mangini M et al (2008) Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg (London, England) 6:S65–S69
Cornélis F, Havez M, Lippa N et al (2013) Radiologically guided percutaneous cryotherapy for soft tissue tumours: a promising treatment. Diagn Interv Imaging 94:364–370
Kurup AN, Callstrom MR (2013) Ablation of musculoskeletal metastases: pain palliation, fracture risk reduction, and oligometastatic disease. Tech Vasc Interv Radiol 16:253–261
White ML, Atwell TD, Kurup AN et al (2016) Recurrence and survival outcomes after percutaneous thermal ablation of oligometastatic melanoma. Mayo Clin Proc 91:288–296
Tuncali K, Morrison PR, Winalski CS et al (2007) MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol 189:232–239
Callstrom MR, Atwell TD, Charboneau JW et al (2006) Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis. Radiology 241:572–580
Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739
Cha CH, Lee FT, Gurney JM et al (2000) CT versus sonography for monitoring radiofrequency ablation in a porcine liver. AJR Am J Roentgenol 175:705–711
Belfiore MP, Ronza FM, Volpe Della T et al (2015) Long-term local disease control in a recurrent soft-tissue sarcoma of the thigh treated by radiofrequency ablation. J Surg Oncol 111:708–710
Xu J, Li J, Zhou X et al (2014) Cryotherapy for local recurrent dermatofibrosarcoma protuberans: experience in 19 patients. Cryobiology 68:134–138
Rosenthal D, Callstrom MR (2012) Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology 262:765–780
Kastler B, Jacamon M, Aubry S et al (2007) Combined bipolar radiofrequency and cementoplasty of bone metastases. J Radiol 88:1242–1247
McQuay HJ, Collins SL, Carroll D, Moore RA (2000) Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev CD001793. doi:10.1002/14651858.CD001793
Kurup AN, Callstrom MR (2010) Image-guided percutaneous ablation of bone and soft tissue tumors. Semin Interv Radiol 27:276–284
Owen D, Laack NN, Mayo CS et al (2014) Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol 4:e143–e149
McDonald R, Probyn L, Poon I et al (2015) Tumor response after stereotactic body radiation therapy to nonspine bone metastases: an evaluation of response criteria. Int J Radiat Oncol Biol Phys 93:879–881
Frassica DA (2003) General principles of external beam radiation therapy for skeletal metastases. Clin Orthop Relat Res S158–164. doi:10.1097/01.blo.0000093057.96273.fb
Maybody M, Tang PQ, Moskowitz CS et al (2016) Pneumodissection for skin protection in image-guided cryoablation of superficial musculoskeletal tumours. Eur Radiol 1–9. doi:10.1007/s00330-016-4456-6
Gangi A, Buy X (2010) Percutaneous bone tumor management. Semin Interv Radiol 27:124–136
Filippiadis DK, Tutton S, Kelekis A (2014) Percutaneous bone lesion ablation. La Radiologia Medica 119:462–469
Munk PL, Murphy KJ, Gangi A, Liu DM (2011) Fire and ice: percutaneous ablative therapies and cement injection in management of metastatic disease of the spine. Semin Musculoskelet Radiol 15:125–134
Deschamps F, Farouil G, Hakime A et al (2012) Percutaneous stabilization of impending pathological fracture of the proximal femur. Cardiovasc Intervent Radiol 35:1428–1432
Acknowledgments
The scientific guarantor of this publication is Dr Sébastien Aubry. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. This study has received funding by the University Hospital of Besançon, France. One of the authors has significant statistical expertise (Chrystelle Vidal). Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. No study subjects or cohorts have been previously reported. Methodology: prospective, observational, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aubry, S., Dubut, J., Nueffer, JP. et al. Prospective 1-year follow-up pilot study of CT-guided microwave ablation in the treatment of bone and soft-tissue malignant tumours. Eur Radiol 27, 1477–1485 (2017). https://doi.org/10.1007/s00330-016-4528-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-016-4528-7